Cell-based Assays World Industry and Market Prospects 2016-2026
Summary
Cell-based assays can provide a more-accurate representation of human in vivo conditions; they are reliable and, most important for drug development companies, they have high efficiency. Increasing prominence of technologies such as microfluidics, label-free systems, 3D cell-based assays and IPSC cell lines will stimulate revenue growth in the cellular testing market from 2015. Our work segments that bioassaying industry and market into two broad categories, with revenue forecasts to 2026 and discussions: • Products • Services To see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com We also divide that medical testing industry into three main applications, again with sales forecasting: • Drug discovery uses • ADME (absorption, distribution, metabolism, excretion) testing • Basic research purposes Besides forecasting revenues for the previous submarkets, our study also breaks its overall world market prediction into these 11 leading national markets, to 2026: • United States (US) • Japan • Germany, United Kingdom (UK), France, Spain, Italy (EU5 countries) • Brazil, Russia, India, China (BRIC nations) And here lie technologies and trends we cover, among others, showing how they shape that worldwide market to 2026: • Stem cells (including IPSCs) for bioassays • 3D cell-based systems • Cell-based assaying for toxicity testing • Increased outsourcing for that cellular screening • Label-free technology • GPCRs (G-protein-coupled receptors) • Miniaturisation and automation • Microfluidics and multiplexing • High-content screening (HCS) • Cell lines for pharma in vitro assays • Cellular tests for the development of biologics (biological drugs) Our 185 page report provides 48 tables and 66 figures covering different market segments categorized by application: drug discovery, ADME, and basic research; as well as by sector: products and services. Ways Cell-Based Assays World Industry and Market Prospects 2016-2026: Products, Services, Drug Discovery, ADME and Basic Research helps: In particular, our new investigation gives you this knowledge to benefit your research, analyses and planning: • Revenues for cellular assays, to 2026, at world level and for five submarkets - explore the prospects for design, production, sales, marketing, demand and spending • Forecasts, to 2026, for 11 countries in the Americas, Europe and Asia - assess the developed and developing national markets for demand and predicted revenues • Prospects for established firms, rising companies and new entrants - examine the product and service portfolios, results, strategies and outlooks for success • Analyses of what stimulates and restrains that industrys participants - investigate the challenges, strengths and competition affecting organisations actions • Interviews with authorities in that field - discover what participants from the industry think, say and do, helping you stay ahead in business knowledge. Information found nowhere else, benefiting your insight, work and influence Our study, produced in-house by our UK-based analysts, provides independent knowledge.